Market Size of Veterinary Infectious Disease Therapeutics Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Veterinary Infectious Disease Therapeutics Market Analysis
Microorganisms are tiny living creatures that are present everywhere, such as bacteria and viruses. Few of the thousands of species of microorganisms invade, multiply, and cause illness in animals and people. Most of the microorganisms live on the skin, in the mouth, upper airways and intestines without causing any harmful disease but some of the microorganism lives in or on a pet, or invades and causes disease depends on the nature of the microorganism and the state of the pet's natural defenses.
According to World Small Animal Veterinary Association (WSAVA), estimates that 60% to 80% of emerging diseases are zoonotic which indicates the importance of veterinarians in the identification, prevention, and control of infectious diseases. For Example, Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year. Increasing prevalence of infectious disease and increasing demand for dairy, meat, and poultry products due to the increasing population size are the key driving factors in the veterinary infectious disease therapeutics market.
